HO 0303

Drug Profile

HO 0303

Alternative Names: HO-03-03; HO/03/03; Truheal

Latest Information Update: 17 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator HealOr
  • Class Anti-inflammatories
  • Mechanism of Action Protein kinase C inhibitors; Protein kinase C stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Chronic wounds; Diabetic foot ulcer

Most Recent Events

  • 17 Jun 2015 No recent reports on development identified - Phase-I for Chronic wounds in Israel (Topical)
  • 17 Jun 2015 No recent reports on development identified - Phase-II/III for Diabetic foot ulcer in India and USA (Topical)
  • 03 Apr 2013 HealOr completes enrolment in its phase II/III trial for Diabetic foot ulcer in USA & India (NCT00926068)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top